Immunosuppression in Inflammatory Bowel Diseases: Standards, New Developments, Future Trends - Falk Symposium 119 (Hardback)K. Fellermann (editor), D. P. Jewell (editor), W. J. Sandborn (editor), J. Scholmerich (editor), E. F. Stange (editor)
- We can order this
The classical immunosuppressants azathioprine and 6-mercaptopurine have long been evidence-based in IBD, but underused. Recently, methotrexate and cyclosporine have also been proven to be effective in certain situations. Newer drugs like tacrolimus, mycophenolate and others may be similarly useful but their potential is still unclear. Finally, the immune modifiers including IL-10 and TNF-antibodies have been successfully subjected to controlled trials. Other experimental drugs discussed in this book are on the horizon.
This volume is the Proceedings of Falk Symposium 119 held in Freiburg-im-Breisgau, Germany, October 3-4, 2000, and covers systematically the field of immunosuppression in inflammatory bowel diseases. It is hoped that it will further the prudent use of these drugs in the proper clinical situations by increasing our understanding of both the mechanisms of action and the clinical benefit to the patient.
Number of pages: 260
Weight: 1250 g
Dimensions: 235 x 155 x 17 mm
Edition: 2001 ed.
You may also be interested in...
Please sign in to write a review